PR Newswire BiotechOriginal article
OMEZA's OCM will be featured in an approved abstract treating a complex chronic burn patient at Fall SAWC Oct.15-18 in Las Vegas
ConferenceOCMPositive
AI Analysis
Summary
OMEZA's OCM product will be featured in an approved abstract at the Fall SAWC Conference in Las Vegas (October 15-18, 2026), presenting a retrospective evaluation of OCM as primary therapy for thermal burn wounds in an adult private practice setting.
Outcome Details
Approved abstract for presentation at Fall SAWC Conference
Importance:3/10
Sentiment:
0.30
conference presentationwound careclinical abstractretrospective study
Read the original article
Published by PR Newswire Biotech on August 31, 2026 11:00 AM
